The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 03, 2012
Filed:
Oct. 18, 2007
Didier Dubreuil, Port Saint Pere, FR;
Muriel Pipelier, Nantes, FR;
Laurent Micouin, Paris, FR;
Thomas Lecourt, Noisy le Sec, FR;
Vivien Lacone, Clichy-la-Garenne, FR;
Marc Bonneville, Vertou, FR;
Jacques Lependu, Nantes, FR;
Anne-laure Turcot-dubois, Nornaison, FR;
Didier Dubreuil, Port Saint Pere, FR;
Muriel Pipelier, Nantes, FR;
Laurent Micouin, Paris, FR;
Thomas Lecourt, Noisy le Sec, FR;
Vivien Lacone, Clichy-la-Garenne, FR;
Marc Bonneville, Vertou, FR;
Jacques Lependu, Nantes, FR;
Anne-Laure Turcot-Dubois, Nornaison, FR;
Centre National de la Recherche Scientifique, Paris, FR;
Universite Paris Descartes, Paris, FR;
Institut National de la Sante et de la Recherche Medicale (INSERM), Paris, FR;
Abstract
The invention relates to α-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the α-galactoceramide analogs. The methods of manufacture of the invention involve the use of unsaturated intermediate compounds which enable to synthesize α-galactoceramide analogs by a mere metathesis reaction. The α-galactoceramide analogs of the invention are useful as active ingredients of pharmaceutical compositions, particularly in pharmaceutical compositions having anti-cancerous properties.